TNF-alpha Modulation for Treatment of Alzheimer's Disease: A 6-Month Pilot Study

ABSTRACT: CONTEXT: Current pharmacologic treatments for Alzheimer's disease (AD) do not prevent long-term clinical deterioration. Tumor necrosis factor (TNF)-alpha, a proinflammatory cytokine, has been implicated in the pathogenesis of AD. OBJECTIVE: To investigate the use of a biologic TNF-alp...

Full description

Saved in:
Bibliographic Details
Main Authors: Tobinick, Edward, Gross, Hyman, Weinberger, Alan, Cohen, Hart
Format: Artigo
Language:Inglês
Published: Medscape 2006
Subjects:
MedGenMed Neurology & Neurosurgery
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1785182/
https://ncbi.nlm.nih.gov/pubmed/16926764
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items